• Curcumin Modulates ISC Differentiation via Wnt/β-Catenin in

  2026-04-30

  This study demonstrates that curcumin alleviates dextran sulfate sodium-induced ulcerative colitis in mice by inhibiting the Wnt/β-catenin signaling pathway and restoring intestinal stem cell (ISC) differentiation. These mechanistic insights advance the understanding of curcumin’s therapeutic potential in mucosal healing and targeted intervention in chronic colitis.

• Antibody-Based Inhibition of CD16 Shedding Enhances ADCC in

  2026-04-30

  This study introduces F9H4, a monoclonal antibody that selectively inhibits the shedding of CD16a and CD16b from immune effector cells, thereby enhancing antibody-dependent cellular cytotoxicity (ADCC) against tumors. The findings provide a substrate-targeted solution to augment Fcγ receptor-mediated anti-tumor responses while avoiding the pleiotropic effects of broad-spectrum protease inhibitors.

• Gentamycin Sulfate in Bacterial Ribosome Fidelity and Resist

  2026-04-29

  Explore the profound role of Gentamycin Sulfate as an aminoglycoside antibiotic in dissecting ribosomal fidelity and resistance mechanisms. This article offers an advanced perspective on assay optimization and translational research, bridging molecular insight with practical application.

• Gentamycin Sulfate: Unlocking Advanced Bacterial Protein Syn

  2026-04-29

  Gentamycin Sulfate stands as a cornerstone aminoglycoside antibiotic for dissecting bacterial protein synthesis, ribosome function, and antibiotic resistance in Gram-negative models. This article delivers actionable workflows, protocol enhancements, and troubleshooting strategies—anchored in the latest evidence—to empower robust, reproducible research using APExBIO’s high-purity reagent.

• Nanoplastics and Cadmium Co-exposure Triggers Intestinal Apo

  2026-04-28

  This study uncovers how simultaneous exposure to polystyrene nanoplastics and cadmium accelerates apoptosis in intestinal cells via the IP3R/Ca2+/STAT3 pathway. These mechanistic insights highlight the importance of calcium chelation strategies for dissecting toxicant-induced cell signaling and inform environmental risk assessment.

• BI 2536: PLK1 Inhibitor for G2/M Arrest and Cancer Research

  2026-04-28

  BI 2536, a potent and selective PLK1 inhibitor, has redefined the precision of cell cycle regulation assays and apoptosis studies in cancer research. APExBIO’s reference-grade reagent enables robust, reproducible workflows from in vitro screening to in vivo xenograft modeling, while the latest mechanistic insights empower researchers to probe mitotic checkpoint control with unprecedented clarity.

• Gentamycin Sulfate (SKU A2514): Reliable Data for Cell Assay

  2026-04-27

  This evidence-based guide addresses real laboratory challenges in cell viability, proliferation, and cytotoxicity assays, demonstrating how Gentamycin Sulfate (SKU A2514) from APExBIO provides researchers with reliable results. Drawing on workflow scenarios and recent literature, it details protocol best practices and vendor selection considerations, ensuring reproducibility and confidence for biomedical scientists.

• Remdesivir (GS-5734): Applied Workflows in Antiviral Researc

  2026-04-27

  Remdesivir (GS-5734) offers researchers robust inhibition of viral RNA synthesis, making it indispensable for coronavirus and Ebola virus research. This article details optimized workflows, troubleshooting strategies, and data-driven protocol enhancements that maximize reproducibility and antiviral discovery power.

• Inhibition of Renal OCT2 and MATE1 by Tropisetron Hydrochlor

  2026-04-26

  This article explores the mechanistic findings of George et al. (2021), demonstrating that Tropisetron Hydrochloride and related 5-HT3 receptor antagonists inhibit renal organic cation transporters OCT2 and MATE1 in vitro. These results provide new context for transporter-mediated drug interactions and pharmacokinetics in preclinical and translational research.

• G418 Sulfate (Geneticin): Optimizing Cell Selection & Antivi

  2026-04-25

  G418 Sulfate (Geneticin) stands out as a gold-standard selection antibiotic for genetic engineering and antiviral research. This article provides a scenario-driven guide for protocol optimization, troubleshooting, and leveraging APExBIO’s ultra-pure formulation for reproducible results across diverse applications.

• Simvastatin (Zocor) in Cell-Based Assays: Evidence-Driven In

  2026-04-24

  This article delivers a scenario-driven, evidence-based exploration of Simvastatin (Zocor) (SKU A8522) as a reliable tool for cell viability, apoptosis, and cytotoxicity assays. Drawing on validated protocols and comparative insights, it guides biomedical researchers and lab technicians through practical challenges in workflow optimization, data interpretation, and vendor selection. The result is a resource that maximizes reproducibility and scientific rigor for users of Simvastatin (Zocor).

• Bufalin: Cardiotonics Empowering Next-Gen Cancer Workflows

  2026-04-24

  Bufalin, a high-purity cardiotonic steroid from APExBIO, is redefining cancer workflows by targeting Serine/Threonine Kinase 33 in triple-negative breast cancer. This guide outlines evidence-based protocols, troubleshooting strategies, and the translational edge that Bufalin brings to apoptosis and cell differentiation assays.

• rTMS Promotes Cognitive Recovery in AD via Cx3cl1-Cx3cr1 Axi

  2026-04-23

  This study demonstrates that repetitive transcranial magnetic stimulation (rTMS) enhances cognitive recovery in Alzheimer’s disease by activating GABAergic neurons and upregulating the Cx3cl1-Cx3cr1 axis, which stimulates microglial phagocytosis and reduces amyloid pathology. The findings elucidate a molecular mechanism for non-invasive rTMS in AD therapy and highlight opportunities for targeted intervention and translational research.

• Forsythoside E: PKM2 Inhibition for Sepsis-Induced Liver Inj

  2026-04-23

  Forsythoside E stands apart as a mechanistically precise PKM2 inhibitor, enabling targeted metabolic reprogramming of macrophages for advanced sepsis-induced liver injury models. Its robust in vitro and in vivo efficacy, validated by recent translational research, positions it as an indispensable tool for immunometabolic studies.

• Super-Enhancer RNA Drives NPC Metastasis via NPM1/c-Myc/NDRG

  2026-04-22

  Jia et al. (2023) reveal a carcinogen-induced super-enhancer RNA (seRNA-NPCm) that promotes nasopharyngeal carcinoma (NPC) metastasis by engaging the NPM1/c-Myc/NDRG1 axis and facilitating chromatin looping. This mechanistic insight clarifies how dietary nitrosamines accelerate NPC progression and underscores new prognostic and experimental targets for future research.

16084 records 1/1073 page Next 12345 下5页 Last page